Abstract |
In this study, two invasive mammary carcinoma cells (MDA-MB-231 and 4T1) were utilized to evaluate the inhibitory activities of platycodin D, osthole, and the two in combination. The anti-proliferative effect was tested using the MTT and BrdU assay, and the combination of 15μM osthole and 75μM platycodin D was used for subsequent analyses. The anti-invasive effect was evaluated by the transwell assay. The results showed that the combination treatment reduced both cell proliferation and invasion. Western blot and real-time PCR revealed that the platycodin D- osthole combination significantly decreased TβRII, Smad2, Smad3 and Smad4 gene or protein expressions, as well as effectively blocked TGF-β-induced phosphorylation of Smad2 and Smad3. Thus, this study demonstrates that the anti- cancer effects of the platycodin D- osthole combination in breast cancer cells involve proliferation inhibition and invasion blockade, both of which may be mediated by perturbations in the TGF-β/Smads pathway.
|
Authors | Yiyi Ye, Xianghui Han, Baofeng Guo, Zhenping Sun, Sheng Liu |
Journal | Environmental toxicology and pharmacology
(Environ Toxicol Pharmacol)
Vol. 36
Issue 1
Pg. 115-24
(Jul 2013)
ISSN: 1872-7077 [Electronic] Netherlands |
PMID | 23603464
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Coumarins
- Receptors, Transforming Growth Factor beta
- Saponins
- Smad Proteins
- Transforming Growth Factor beta
- Triterpenes
- platycodin D
- Protein Serine-Threonine Kinases
- Receptor, Transforming Growth Factor-beta Type II
- osthol
|
Topics |
- Animals
- Antineoplastic Agents
(administration & dosage)
- Breast Neoplasms
(drug therapy, genetics, metabolism)
- Carcinoma
(drug therapy, genetics, metabolism)
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Coumarins
(administration & dosage)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Mice
- Protein Serine-Threonine Kinases
(genetics, metabolism)
- Receptor, Transforming Growth Factor-beta Type II
- Receptors, Transforming Growth Factor beta
(genetics, metabolism)
- Saponins
(administration & dosage)
- Smad Proteins
(genetics, metabolism)
- Transforming Growth Factor beta
(pharmacology)
- Triterpenes
(administration & dosage)
|